'ASIA' - Autoimmune/inflammatory syndrome induced by adjuvants

Journal of Autoimmunity

Volumn 36, Issue 1, 2011, Pages 4-8

  Shoenfeld, Yehuda ^a,b   Agmon Levin, Nancy ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adjuvant; Autoimmunity; Gulf war syndrome (GWS); Macrophagic myofasciitis syndrome (MMF); Silicone; Vaccine

Indexed keywords

ALUMINUM POTASSIUM SULFATE; AUTOANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; FREUND ADJUVANT; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; LIPOPOLYSACCHARIDE; MEASLES MUMPS RUBELLA VACCINE; ORAL POLIOMYELITIS VACCINE; SILICONE;

ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE INFLAMMATORY SYNDROME INDUCED BY ADJUVANT; AUTOIMMUNE THROMBOCYTOPENIA; BACTERIAL CELL WALL; CLINICAL FEATURE; CPG ISLAND; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOPATHOGENESIS; INFECTION; INFLAMMATORY DISEASE; MACROPHAGIC MYOFASCIITIS SYNDROME; MYELITIS; MYOCARDITIS; NONHUMAN; PERSIAN GULF SYNDROME; PRIORITY JOURNAL; REVIEW; SILICONOSIS; VACCINATION; VACCINATION REACTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; AUTOIMMUNE DISEASES; FASCIITIS; HUMANS; INFLAMMATION; MYOSITIS; PERSIAN GULF SYNDROME; SILICONES; SYNDROME; VACCINES;

EID: 79151484198     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.07.003     Document Type: Review

References (51)

1. Shoenfeld Y., Selmi C., Zimlichman E., Gershwin M.E. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 2008 Dec, 31(4):325-330.
2. Youinou P., Pers J.O., Gershwin M.E., Shoenfeld Y. Geo-epidemiology and autoimmunity. J Autoimmun 2010 May, 34(3):J163-J167.
3. Shapira Y., Agmon-Levin N., Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 2010 May, 34(3):J168-J177.
4. Borchers A.T., Naguwa S.M., Shoenfeld Y., Gershwin M.E. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010 Mar, 9(5):A277-A287.
5. Shoenfeld Y., Gilburd B., Abu-Shakra M., Amital H., Barzilai O., Berkun Y., et al. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases - 2008. Isr Med Assoc J 2008 Jan, 10(1):3-7.
6. Shoenfeld Y., Zandman-Goddard G., Stojanovich L., Cutolo M., Amital H., Levy Y., et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases - 2008. Isr Med Assoc J 2008 Jan, 10(1):8-12.
7. Zifman E., Amital H., Gilburd B., Shoenfeld Y. Antioxidants and smoking in autoimmune disease - opposing sides of the seesaw?. Autoimmun Rev 2008 Dec, 8(2):165-169.
8. Kivity S., Agmon-Levin N., Blank M., Shoenfeld Y. Infections and autoimmunity. Trends in Immunology 2009, 30(8):409-414.
9. Agmon-Levin N., Paz Z., Israeli E., Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol 2009, 5(11):648-652.
10. Zandman-Goddard G., Blank M., Ehrenfeld M., Gilburd B., Peter J., Shoenfeld Y. A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants. J Rheumatol 1999 Jan, 26(1):73-77.
11. Bar-Meir E., Eherenfeld M., Shoenfeld Y. Silicone gel breast implants and connective tissue disease - a comprehensive review. Autoimmunity 2003 Jun, 36(4):193-197.
12. Agmon-Levin N., Shoenfeld Y. Chronic fatigue syndrome with autoantibodies - the result of an augmented adjuvant effect of Hepatitis B vaccine and silicone implant. Autoimmun Rev 2008, 8(1):52-55.
13. Israeli Eitan, Agmon-Levin Nancy, Blank Miri, Shoenfeld Yehuda Adjuvants and autoimmunity. Lupus 2009, 18(13):1217-1225.
14. Marrack P., McKee A.S., Munks M.W. Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol 2009 Apr, 9(4):287-293.
15. McKee A.S., Munks M.W., MacLeod M.K., Fleenor C.J., Van Rooijen N., Kappler J.W., et al. Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J Immunol 2009 Oct 1, 183(7):4403-4414.
16. Kool M., Soullié T., van Nimwegen M., Willart M.A., Muskens F., Jung S., et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med 2008 Apr 14, 205(4):869-882.
17. Eisenbarth S.C., Colegio O.R., O'Connor W., Sutterwala F.S., Flavell R.A. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008, 453:1122-1126.
18. Hornung V., Bauernfeind F., Halle A., Samstad E.O., Kono H., Rock K.L., et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 2008 Aug, 9(8):847-856.
19. Satoh M., Reeves W.H. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med 1994, 180:2341-2346.
20. Reeves W.H., Lee P.Y., Weinstein J.S., Satoh M., Lu L. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol 2009 Sep, 30(9):455-464.
21. Santoro D., Stella M., Montalto G., Castellin S. Lupus nephritis after Hepatitis B vaccination: an uncommon complication. Clin Nephrol 2007, 67:61-63.
22. Barzilai O., Sherer Y., Ram M., Izhaky D., Anaya J.M., Shoenfeld Y. Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann N Y Acad Sci 2007 Jun, 1108:567-577.
23. Edwards C.J., Syddall H., Jameson K., Williams E.L., Polosa R., Goswami R., et al. Hertfordshire Cohort Study Group. The presence of anticardiolipin antibodies in adults may be influenced by infections in infancy. QJM 2008 Jan, 101(1):41-47.
24. Classen J.B., Classen D.C. Clustering of cases of insulin dependent diabetes (IDDM) occurring three years after hemophilus influenza B (HiB) immunization support causal relationship between immunization and IDDM. Autoimmunity 2002 Jul, 35(4):247-253.
25. Arbuckle M.R., McClain M.T., Rubertone M.V., Scofield R.H., Dennis G.J., James J.A., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003, 349:1526-1533.
26. Rose N.R. Autoimmunity, infection and adjuvants. Lupus 2010, 19(4):354-358.
27. Mikaeloff Y., Caridade G., Suissa S., Tardieu M. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 2009 Mar 10, 72(10):873-880.
28. Vaccines adverse events reporting system (CDC). http://vaers.hhs.gov/index.
29. Evans D., Cauchemez S., Hayden F.G. "Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events. J Infect Dis 2009 Aug 1, 200(3):321-328.
30. Lasky T., Terracciano G.J., Magder L., Koski C.L., Ballesteros M., Nash D., et al. The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 1998, 339:1797-1802.
31. Hogenesch H., Azcona-Olivera J., Scott-Moncrieff C., Snyder P.W., Glickman L.T. Vaccines induced autoimmunity in dogs. Adv Vet Med 1999, 41:733-747.
32. Classen J.B. The timing of immunization affects the development of diabetes in rodents. Autoimmunity 1996, 24(137-45).
33. Koppang E.O., Bjerkås I., Haugarvoll E., Chan E.K., Szabo N.J., Ono N., et al. Vaccination-induced systemic autoimmunity in farmed Atlantic salmon. J Immunol 2008, 181:4807-4814.
34. Balofsky A., Agmon-Levin N., Shoenfeld Y. The new H1N1 and HPV vaccines and old fears. Curr Opin Rheumatol 2010 May 18.
35. Gherardi R.K., Coquet M., Cherin P., Authier F.J., Laforet P., Belec L., et al. Macrophagic myofasciitis: an emerging entity. Groupe d'Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l'Association Francaise contre les Myopathies (AFM). Lancet 1998, 352:347-352.
36. Gherardi R.K., Coquet M., Cherin P., Belec L., Moretto P., Dreyfus P.A., et al. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 2001 Sep, 124(Pt 9):1821-1831.
37. Exley C., Swarbrick L., Gherardi R.K., Authier F.J. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. Med Hypotheses 2009 Feb, 72(2):135-139.
38. Authier F.J., Cherin P., Creange A., Bonnotte B., Ferrer X., Abdelmoumni A., et al. Central nervous system disease in patients with macrophagic myofasciitis. Brain 2001 May, 124(Pt 5):974-983.
39. Israeli E, Agmon-Levin N, Blank M and Shoenfeld Y. Macrophagic myofaciitis a vaccine (alum) autoimmune related disease. CRAI 2011.
40. Guis S., Pellissier J.F., Nicoli F., Reviron D., Mattei J.P., Gherardi R.K., et al. HLA-DRB1*01 and macrophagic myofasciitis. Arthritis Rheum 2002 Sep, 46(9):2535-2537.
41. Ablin J.N., Shoenfeld Y., Buskila D. Fibromyalgia, infection and vaccination: two more parts in the etiological puzzle. J Autoimmun 2006 Nov, 27(3):145-152.
42. Ortega-Hernandez O.D., Shoenfeld Y. Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence?. Ann N Y Acad Sci 2009 Sep, 1173:600-609.
43. Asa P.B., Cao Y., Garry R.F. Antibodies to squalene in Gulf War syndrome. Exp Mol Pathol 2000, 68:55-64.
44. Shoaib B.O., Patten B.M. Human adjuvant disease: presentation as a 414 multiple sclerosis-like syndrome. South Med J 1996, 89:179-188.
45. Hennekens C.H., Lee I.M., Cook N.R., Hebert P.R., Karlson E.W., LaMotte F., et al. Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study. JAMA 1996, 275(8):616-621.
46. Janowsky E.C., Kupper L.L., Hulka B.S. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med 2000, 342(11):781-790.
47. Vasey F.B., Zarabadi S.A., Seleznick M., Ricca L. Where there's smoke there's fire: the silicone breast implant controversy continues to flicker: a new disease that needs to be defined. J Rheumatol 2003, 30(10):2092-2094.
48. Fryzek J.P., Signorello L.B., Hakelius L., Feltelius N., Ringberg A., Blot W.J., et al. Self-reported symptoms among women after cosmetic breast implant and breast reduction surgery. Plast Reconstr Surg 2001, 107(1):206-213.
49. Brown S.L., Parmentier C.M., Woo E.K., Vishnuvajjala R.L., Headrick M.L., et al. Silicone gel breast implant rupture, extracapsular silicone, and health status in a population of women. J Rheumatol 2001, 28(5):996-1003.
50. Vermeulen R.C., Scholte H.R. Rupture of silicone gel breast implants and symptoms of pain and fatigue. J Rheumatol 2003 Oct, 30(10):2263-2267.
51. Burek C.L., Talor M.V. Environmental triggers of autoimmune thyroiditis. J Autoimmun 2009 Nov-Dec, 33(3-4):183-189.